Rafferty Asset Management
PCVX icon

Rafferty Asset Management’s Vaxcyte PCVX Stock Holding History

Rafferty Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.53M Sell
60,776
-17,626
-22% -$957K 0.01% 483
2026
Q1 		$4.56M Sell
78,402
-55,362
-41% -$3.01M 0.02% 416
2025
Q4 		$6.17M Sell
133,764
-15,650
-10% -$700K 0.02% 367
2025
Q3 		$5.38M Sell
149,414
-15,409
-9% -$511K 0.02% 409
2025
Q2 		$5.36M Buy
164,823
+33,011
+25% +$1.08M 0.02% 385
2025
Q1 		$4.98M Sell
131,812
-15,624
-11% -$1.25M 0.02% 371
2024
Q4 		$12.1M Buy
147,436
+82,940
+129% +$8.24M 0.04% 259
2024
Q3 		$7.37M Sell
64,496
-30,187
-32% -$2.72M 0.03% 333
2024
Q2 		$7.15M Sell
94,683
-31,481
-25% -$2.14M 0.03% 337
2024
Q1 		$8.62M Sell
126,164
-32,249
-20% -$2.23M 0.03% 323
2023
Q4 		$9.95M Sell
158,413
-5,481
-3% -$285K 0.04% 281
2023
Q3 		$8.36M Sell
163,894
-415
-0.3% -$20.5K 0.05% 272
2023
Q2 		$8.21M Sell
164,309
-15,572
-9% -$738K 0.05% 263
2023
Q1 		$6.74M Sell
179,881
-10,421
-5% -$442K 0.05% 304
2022
Q4 		$9.12M Buy
190,302
+96,889
+104% +$3.8M 0.08% 203
2022
Q3 		$2.24M Buy
93,413
+42,030
+82% +$1.07M 0.02% 485
2022
Q2 		$1.12M Sell
51,383
-6,665
-11% -$154K 0.01% 611
2022
Q1 		$1.4M Buy
58,048
+11,792
+25% +$258K 0.01% 707
2021
Q4 		$1.1M Buy
46,256
+18,177
+65% +$423K 0.01% 825
2021
Q3 		$712K Sell
28,079
-24,827
-47% -$602K ﹤0.01% 962
2021
Q2 		$1.19M Sell
52,906
-37,877
-42% -$775K 0.01% 823
2021
Q1 		$1.79M Buy
90,783
+81,771
+907% +$2.06M 0.01% 652
2020
Q4 		$239K Buy
+9,012
New +$335K ﹤0.01% 930

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Rafferty Asset Management's PCVX Position: Q2 2026 in Review

Rafferty Asset Management reduced its Vaxcyte (PCVX) stake by 22% in Q2 2026, selling an estimated $957K and leaving 60,776 shares worth $3.53M. The position accounts for 0.01% of the portfolio, ranked #483.

Rafferty Asset Management first reported a position in PCVX in Q4 2020 and has held it in 23 quarters since. The position peaked at $12.1M in Q4 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Rafferty Asset Management held 60,776 shares of Vaxcyte worth $3.53M as of Q2 2026.
  • Rafferty Asset Management sold 17,626 Vaxcyte shares in Q2 2026, an estimated $957K.
  • Vaxcyte made up 0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #483 holding.
  • Rafferty Asset Management first reported a position in Vaxcyte in Q4 2020 and has held it in 23 quarters since.
  • Rafferty Asset Management's Vaxcyte position peaked at $12.1M in Q4 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.